Announcements Trials
Browse Landscape

Phase

Phase 3 49Phase 2 40Phase 1 7Phase 1/2 4Phase 2/3 3Phase NA 2Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 25INDUSTRY 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

sintilimab 1diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine 1Vincristine 1Sevoflurane 1Rituximab 1Propofol 1Pleurodesis 1Mitoxantrone 1Methotrexate 1Introns 1Interferon alpha-2 1Idarubicin 1Gastrointestinal Microbiome 1Drug Therapy 1Docetaxel 1Dexamethasone 1Dasatinib 1Danazol 1Cytarabine 1Clorazepate Dipotassium 1Carboplatin 1Anesthesia, Epidural 123-valent pneumococcal capsular polysaccharide vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NETWORK × Methotrexate × Clear all
NCT02323659 2022-01-13

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Polish Lymphoma Research Group

Phase 4 Terminated
100 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡